1. Baker H. et al "Absorption, utilization and clinical effectiveness of allithiamines compared to water-soluble thiamines" J Nutr Sci Vitaminol (Tokyo). 1976 Aug;22 SUPPL:63-8
2. MATSUKAWA T. et al "Products of the reaction between thiamine and ingredients of the plants of Allium genus: detection of allithiamine and its homologs" Science. 1953 Sep 18;118(3064):325-7
3. Berrone E. et al "Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose" J Biol Chem. 2006 Apr 7;281(14):9307-13
4. Du X. et al "Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes" Diabetologia. 2008 Oct;51(10):1930-2
5. Alcazar-Leyva S. et al "Could thiamine pyrophosphate be a regulator of the nitric oxide synthesis in the endothelial cell of diabetic patients?" Med Hypotheses 2011 May;76(5):629-31
6. Kihm LP. "Benfotiamine Protects against Peritoneal and Kidney Damage in Peritoneal Dialysis" J Am Soc Nephrol. 2011 May; 22(5): 914รขโฌโ926
7. Hurt JK. et al "Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine" Plos one, 30 Oct 2012, 7(10):e48562
8. Mann RH. "Impaired Thiamine Metabolism in Amyotrophic Lateral Sclerosis and Its Potential Treatment With Benfotiamine: A Case Report and a Review of the Literature" Cureus 2023 Jun 16;15(6):e40511
The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.